PNPLA2 and metabolic dysfunction-associated steatohepatitis: Intriguingly, hepatic mRNA levels of JMJD3, TFEB, ULK1, ATG7, and ATGL, were all decreased in both simple steatosis and advanced NASH-fibrosis patients compared to normal subjects (Fig. 9a).